Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Andrew Rosser, Cordula Stover, Manish Pareek & Galina V. Mukamolova. (2017) Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection. Critical Reviews in Microbiology 43:5, pages 621-630.
Read now
Read now
David N McMurray & Lan H Ly. (2009) TB vaccines: the paradigms they are a-shifting. Expert Review of Vaccines 8:12, pages 1615-1618.
Read now
Read now
Pramod K Giri & Gopal K Khuller. (2008) Is intranasal vaccination a feasible solution for tuberculosis?. Expert Review of Vaccines 7:9, pages 1341-1356.
Read now
Read now
Lan H Ly & David N McMurray. (2008) Tuberculosis: vaccines in the pipeline. Expert Review of Vaccines 7:5, pages 635-650.
Read now
Read now
Articles from other publishers (16)
Elaine A. Yu, Serene H. John, Elizabeth C. Tablante, Christine A. King, John Kenneth, David G. Russell & Saurabh Mehta. (2017) Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status. PLOS ONE 12:10, pages e0185640.
Crossref
Crossref
Sandeep Kumar Dhanda, Pooja Vir, Deepak Singla, Sudheer Gupta, Shailesh Kumar & Gajendra P. S. Raghava. (2016) A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis. PLOS ONE 11:4, pages e0153771.
Crossref
Crossref
Hongxia Niu, Jinxiu Peng, Chunxiang Bai, Xun Liu, Lina Hu, Yanping Luo, Bingxiang Wang, Ying Zhang, Jianzhu Chen, Hongjuan Yu, Qiaoyang Xian & Bingdong Zhu. (2015) Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice. PLOS ONE 10:6, pages e0130641.
Crossref
Crossref
Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff, Darius Soonawala, Corine Prins, David A. Hokey, Dawn M. O’Dee, Andrew Graves, Birgit Thierry-Carstensen, Lars V. Andreasen, Morten Ruhwald, Adriëtte W. de Visser, Else Marie Agger, Tom H.M. Ottenhoff, Ingrid Kromann & Peter Andersen. (2014) A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine 32:52, pages 7098-7107.
Crossref
Crossref
Priya Saikumar Lakshmi, Dheeraj Verma, Xiangdong Yang, Bethany Lloyd & Henry Daniell. (2013) Low Cost Tuberculosis Vaccine Antigens in Capsules: Expression in Chloroplasts, Bio-Encapsulation, Stability and Functional Evaluation In Vitro. PLoS ONE 8:1, pages e54708.
Crossref
Crossref
T Mark Doherty. (2012) Immunotherapy for TB. Immunotherapy 4:6, pages 629-647.
Crossref
Crossref
Philana Ling Lin, Jes Dietrich, Esterlina Tan, Rodolfo M. Abalos, Jasmin Burgos, Carolyn Bigbee, Matthew Bigbee, Leslie Milk, Hannah P. Gideon, Mark Rodgers, Catherine Cochran, Kristi M. Guinn, David R. Sherman, Edwin Klein, Christopher Janssen, JoAnne L. Flynn & Peter Andersen. (2012) The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. Journal of Clinical Investigation 122:1, pages 303-314.
Crossref
Crossref
Jaap T. van Dissel, Darius Soonawala, Simone A. Joosten, Corine Prins, Sandra M. Arend, Peter Bang, Pernille Nyholm Tingskov, Karen Lingnau, Jan Nouta, Søren T. Hoff, Ida Rosenkrands, Ingrid Kromann, Tom H.M. Ottenhoff, T. Mark Doherty & Peter Andersen. (2011) Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. Vaccine 29:11, pages 2100-2109.
Crossref
Crossref
Claus Aagaard, Truc Hoang, Jes Dietrich, Pere-Joan Cardona, Angelo Izzo, Gregory Dolganov, Gary K Schoolnik, Joseph P Cassidy, Rolf Billeskov & Peter Andersen. (2011) A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nature Medicine 17:2, pages 189-194.
Crossref
Crossref
G. G. Guerrero & C. Locht. (2011)
Recombinant HBHA Boosting Effect on BCG-Induced Immunity against
Mycobacterium tuberculosis
Infection
. Clinical and Developmental Immunology 2011, pages 1-8.
Crossref
Crossref
Jaap T. van Dissel, Sandra M. Arend, Corine Prins, Peter Bang, Pernille Nyholm Tingskov, Karen Lingnau, Jan Nouta, Michèl R. Klein, Ida Rosenkrands, Tom H.M. Ottenhoff, Ingrid Kromann, T. Mark Doherty & Peter Andersen. (2010) Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers. Vaccine 28:20, pages 3571-3581.
Crossref
Crossref
Daniel Restrepo-Montoya, Carolina Vizcaíno, Luis F Niño, Marisol Ocampo, Manuel E Patarroyo & Manuel A Patarroyo. (2009) Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics 10:1.
Crossref
Crossref
JES DIETRICH & T. MARK DOHERTY. (2009)
Interaction of
Mycobacterium tuberculosis
with the host: consequences for vaccine development
. APMIS 117:5-6, pages 440-457.
Crossref
Crossref
C. Shi, S. Yuan, H. Zhang, T. Zhang, L. Wang & Z. Xu. (2009)
Cell-Mediated Immune Responses and Protective Efficacy against Infection with
Mycobacterium tuberculosis
Induced by Hsp65 and hIL-2 Fusion Protein in Mice
. Scandinavian Journal of Immunology 69:2, pages 140-149.
Crossref
Crossref
Steven C. Derrick, L.P. Perera, Veerabadran Dheenadhayalan, Amy Yang, Kristopher Kolibab & Sheldon L. Morris. (2008) The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis. Vaccine 26:48, pages 6092-6098.
Crossref
Crossref
Sandra M Newton, Andrew J Brent, Suzanne Anderson, Elizabeth Whittaker & Beate Kampmann. (2008) Paediatric tuberculosis. The Lancet Infectious Diseases 8:8, pages 498-510.
Crossref
Crossref